Research Topics
Species | Bruce BaconSummaryAffiliation: Saint Louis University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1R E Fleming
Department of Pediatrics, Saint Louis University School of Medicine, St Louis, MO 63104, USA
Proc Natl Acad Sci U S A 96:3143-8. 1999..These data support the model for HH in which HFE mutations lead to inappropriately low crypt cell iron, with resultant stabilization of DMT1(IRE) mRNA, up-regulation of DMT1, and increased absorption of dietary iron...
Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosisR E Fleming
Department of Pediatrics, Saint Louis University School of Medicine, 1402 South Grand Boulevard, St Louis, MO 63104, USA
Proc Natl Acad Sci U S A 98:2707-11. 2001..Analysis of mice from crosses between C57BL/6 and AKR mice should allow the mapping and subsequent identification of genes modifying the severity of iron loading in this murine model of HH...
Hereditary hemochromatosis in the post-HFE eraJohn K Olynyk
School of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital, Fremantle, Western Australia, Australia
Hepatology 48:991-1001. 2008....
Hemochromatosis: discovery of the HFE geneBruce R Bacon
Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, USA
Mo Med 109:133-6. 2012..The medical literature describes a colorful history of HH with important contributions from faculty at Saint Louis University...
Triple therapy with boceprevir for HCV genotype 1 infection: phase III results in relapsers and nonrespondersBruce R Bacon
Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St Louis, Mo 63110 0250, USA
Liver Int 32:51-3. 2012..Resistance needs to be carefully monitored as these newer and more potent drugs are added to IFN and RBV backbone drugs. Adverse events will be more frequent and will require special attention...
Expression of iron-related genes in human brain and brain tumorsMilla M Hänninen
Institute of Medical Technology and School of Medicine, University of Tampere, Tampere University Hospital, Tampere, Finland
BMC Neurosci 10:36. 2009..The specimens included 5 normal brain tissue samples, 4 meningiomas, one medulloblastoma, 3 oligodendrocytic gliomas, 2 oligoastrocytic gliomas, 8 astrocytic gliomas, and 3 astrocytoma cell lines...
New therapies for hepatitis C virus infectionBruce R Bacon
Division of Gastroenterology and Hepatology, Saint Louis University Liver Center at Saint Louis University School of Medicine, USA
Mo Med 108:255-9. 2011..We now are at the cusp of yet another such overhaul with the protease inhibitors about to be introduced into the market...
Boceprevir for previously treated chronic HCV genotype 1 infectionBruce R Bacon
Saint Louis University School of Medicine, St Louis, Mo 63110 0250, USA
N Engl J Med 364:1207-17. 2011..Boceprevir, a protease inhibitor that binds to the HCV nonstructural 3 (NS3) active site, has been suggested as an additional treatment...
Hemochromatosis: diagnosis and managementB R Bacon
Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St Louis, Missouri 63110 0250, USA
Gastroenterology 120:718-25. 2001..With the identification of the HFE gene, we are beginning to unravel many of the mysteries of both normal iron absorption and the disorder of iron metabolism found in patients with HH...
Into the light: strategies for battling hepatitis CBruce R Bacon
Division of Gastroenterology and Hepatology, Saint Louis University, 3635 Vista Ave, FDT 9th Fl S, St Louis, MO 63110, USA
Am J Manag Care 13:S319-26. 2007..Future pharmacologic agents are currently in development for patients failing treatment or those who have relapsed...
HFE genotype in patients with hemochromatosis and other liver diseasesB R Bacon
Saint Louis University School of Medicine, Missouri, USA
Ann Intern Med 130:953-62. 1999..Hereditary hemochromatosis is a common inherited disorder of iron metabolism. The gene HFE, which contains two missense mutations (C282Y and H63D), was recently identified...
Treatment for chronic hepatitis CBruce R Bacon
Division of Gastroenterology and Hepatology, Saint Louis University Liver Center, Saint Louis University School of Medicine, 3635 Vista Avenue at Grand Boulevard, St. Louis, MO 63110-0250, USA
Curr Gastroenterol Rep 5:1-2. 2003
Assessing evidence from clinical trials in chronic hepatitis CB R Bacon
Division of Gastroenterology and Hepatology, Saint Louis University Liver Center, Saint Louis University School of Medicine, St Louis, MO 63110, USA
J Viral Hepat 13:1-5. 2006..The articles in this supplement describe the issues in clinical trial design and the evaluation of evidence from clinical trials in patients with chronic hepatitis C...
Treatment issues with chronic hepatitis C: special populations and pharmacy strategiesBruce R Bacon
Saint Louis University, Division of Gastroenterology 3635 Vista Ave, St Louis, MO 63110 2539, USA
Am J Manag Care 11:S296-306; quiz S307-11. 2005....
Certificate of added qualification in transplant hepatologyBruce R Bacon
Division of Gastroenterology and Hepatology, Saint Louis University Liver Center, Saint Louis University School of Medicine, 3635 Vista Avenue at Grand Blvd, St. Louis, MO 63110, USA
Liver Transpl 11:4-6. 2005
Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT resultsBruce R Bacon
Saint Louis University Liver Center, Saint Louis University School of Medicine, St Louis, Mo 63110 0250, USA
Hepatology 49:1838-46. 2009....
Subspecialty certification in transplant hepatologyBruce R Bacon
Saint Louis University School of Medicine, St. Louis, MO, USA
Liver Transpl 13:1479-81. 2007
Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferonA M Di Bisceglie
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, MO, USA
Hepatology 33:704-7. 2001..This study suggests that the combination of IFN and ribavirin is a useful modality of therapy in patients with chronic hepatitis C who did not respond to IFN alone...
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferonAdrian M Di Bisceglie
Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St Louis, MO, USA
Hepatology 53:1100-8. 2011..CONCLUSION: Long-term maintenance peginterferon in patients with advanced chronic hepatitis C is associated with an excess overall mortality, which was primarily due to nonliver-related causes among patients with bridging fibrosis...
HFE gene knockout produces mouse model of hereditary hemochromatosisX Y Zhou
Edward A Doisy Department of Biochemistry and Molecular Biology, St Louis University School of Medicine, 1402 South Grand Boulevard, St Louis, MO 63104, USA
Proc Natl Acad Sci U S A 95:2492-7. 1998..The knockout mouse model of HH will facilitate investigation into the pathogenesis of increased iron accumulation in HH and provide opportunities to evaluate therapeutic strategies for prevention or correction of iron overload...
Molecular medicine and hemochromatosis: at the crossroadsB R Bacon
Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri, USA
Gastroenterology 116:193-207. 1999
Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapyM A Khan
Department of Internal Medicine, Saint Louis University School of Medicine, 1402 South Grand Blvd, St. Louis, MO 63104, USA
Hepatogastroenterology 48:212-5. 2001..This however did not reach statistical significance. CONCLUSIONS: Hepatic alpha-smooth muscle actin expression, as a marker of hepatic stellate cell activation appears reversible and tends to correlate with necroinflammatory activity...
Hepatology in the new millennium. Advances in viral hepatitis, hepatic disorders, and liver transplantationS Ramrakhiani
Department of Internal Medicine, Saint Louis University School of Medicine, Missouri, USA
Med Clin North Am 84:1085-105. 2000..Liver transplantation has been established as an effective therapy for patients with end-stage liver disease...
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trialA M Di Bisceglie
Saint Louis University School of Medicine, St Louis, MO 63104, USA
Hepatology 32:135-8. 2000....
Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tractS Parkkila
Edward A Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, MO 63104, USA
Proc Natl Acad Sci U S A 94:2534-9. 1997....
Ascorbate-stimulated lipid peroxidation and non-heme iron concentrations in Alzheimer diseaseA C Andorn
Department of Psychiatry, Saint Louis University School of Medicine, MO 63014, USA
Mol Chem Neuropathol 33:15-26. 1998....
Intracellular signaling pathways in stellate cell activationR S Britton
Department of Internal Medicine, Saint Louis University School of Medicine, Missouri 63110, USA
Alcohol Clin Exp Res 23:922-5. 1999..Implications for alcohol-induced hepatic fibrosis and future directions for research will also be discussed...
Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cellsA Waheed
Edward A Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St Louis, MO 63104, USA
Proc Natl Acad Sci U S A 94:12384-9. 1997..The block in intracellular transport, accelerated turnover, and failure of the C282Y protein to be presented normally on the cell surface provide a possible basis for impaired function of this mutant protein in HH...
Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis CM Naeem
Department of Internal Medicine, Saint Louis University School of Medicine, Missouri 63110, USA
Am J Gastroenterol 96:2468-72. 2001..These changes do not seem to be associated with clinical signs or complications and triglyceride levels decline while patients are still on therapy and return to normal after stopping...
Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosisS Parkkila
The Edward A Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, MO 63104, USA
Proc Natl Acad Sci U S A 94:13198-202. 1997..These findings also raise the question of whether mutations in the HFE gene can disrupt this association and thereby contribute to some forms of neonatal iron overload...
Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosisR E Fleming
Department of Pediatrics, Saint Louis University School of Medicine, St Louis, MO 63104, USA
Proc Natl Acad Sci U S A 97:2214-9. 2000....
Orchestration of iron homeostasisRobert E Fleming
Saint Louis University School of Medicine, St. Louis, USA
N Engl J Med 352:1741-4. 2005
Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis CStephen A Harrison
Saint Louis University Liver Center, Saint Louis University, St Louis, MS, USA
Clin Gastroenterol Hepatol 3:604-9. 2005..A control group (group 2) of 231 CHC patients was identified by using a 2-year database (January 2000-June 2001) of patients without evidence of greater than 33% steatosis or SH...
Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imagingJohn K Olynyk
School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia
Am J Gastroenterol 100:837-41. 2005..The product of HIC and age is highly sensitive and specific for diagnosis of high-grade fibrosis and can be obtained using MRI...
Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registryKris V Kowdley
University of Washington, Seattle, 98195, USA
Gastroenterology 129:494-503. 2005..We examined the effect of HFE mutations on posttransplantation survival in patients with hepatic iron overload...
Chronic hepatitis C: an age wave of disease burdenJohn G McHutchison
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
Am J Manag Care 11:S286-95; quiz S307-11. 2005..This article reviews the epidemiology, natural history, clinical and economic burden, and screening and treatment options for HCV...
Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology, screening, treatment, and preventionStephen A Harrison
Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, TX, USA
Med Clin North Am 89:391-409. 2005..Palliative measures, including ablative therapy and chemoembolization, can be used. With increasing clinical recognition,hemochromatosis should be diagnosed earlier and progression to cirrhosis and HCC should be minimized...
Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitisKatherine L Leicester
School of Medicine and Pharmacology, University of Western Australia, Perth, Australia
Liver Int 26:559-65. 2006..In hepatitis C, an increased number of CD14-positive cells are associated with high inflammatory activity...
Pathophysiology of hereditary hemochromatosisRobert E Fleming
Department of Pediatrics, Saint Louis University Liver Center, Saint Louis University School of Medicine, St Louis, Missouri 63104, USA
Semin Liver Dis 25:411-9. 2005..The mechanism by which HFE influences hepcidin expression is an area of current investigation and may offer insights into the phenotypic variability observed in persons with mutations in HFE...
Splenectomy for thrombocytopenia in patients with hepatitis C cirrhosisPaul H Hayashi
Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, 3635 Vista Avenue, FDT 9th Floor, St Louis, Mo 63110 0250, USA
J Clin Gastroenterol 40:740-4. 2006..Many patients with hepatitis C cirrhosis and low Model for End-Stage Liver Disease scores are too early for transplant but too thrombocytopenic to treat with interferon...
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3Mitchell L Shiffman
Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA
N Engl J Med 357:124-34. 2007..We conducted a large, randomized, multinational, noninferiority trial to determine whether similar efficacy could be achieved with only 16 weeks of treatment with peginterferon alfa-2a and ribavirin...
Effect of phorbol ester and platelet-derived growth factor on protein kinase C in rat hepatic stellate cellsYoshimasa Kobayashi
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Saint Louis University Liver Center, Saint Louis University School of Medicine, St Louis, MO, USA
Liver Int 27:1066-75. 2007..This study investigated the expression and regulation of protein kinase C (PKC) in HSC...
Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virusJohn G McHutchison
ALT Alliance for Liver Therapy Group, Division of Gastroenterology and Hepatology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
Hepatology 46:1341-9. 2007..The data support further clinical studies of CPG 10101 for treating chronic HCV infection...
Making it happen: managed care considerations in vanquishing hepatitis CJohn G McHutchison
Duke Clinical Research Institute, Duke University Medical Center, P O Box 17969, Durham, NC 27715, USA
Am J Manag Care 13:S327-36; quiz S337-40. 2007....
Clinical penetrance of hereditary hemochromatosisBruce R Bacon
N Engl J Med 358:291-2. 2008
Pathogenesis of hereditary hemochromatosisRobert E Fleming
Department of Pediatrics, Saint Louis University School of Medicine, Cardinal Glennon Childrens Hospital, 1465 S Grand Blvd, St Louis, MO 63104, USA
Clin Liver Dis 8:755-73, vii. 2004..Two major hypotheses have been proposed to explain the pathogenesis of HFE-related hereditary hemochromatosis: the hepcidin hypothesis and the duodenal crypt cell programming hypothesis...
Decreased liver hepcidin expression in the Hfe knockout mouseKaashif A Ahmad
Department of Pediatrics, Saint Louis University School of Medicine, 1402 South Grand Avenue, St Louis, MO 63130, USA
Blood Cells Mol Dis 29:361-6. 2002..We speculate that decreased hepcidin expression relative to body iron stores contributes to the iron homeostasis abnormalities characteristic of HH...
Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitisBrent A Neuschwander-Tetri
Department of Internal Medicine, Saint Louis University Liver Center, Saint Louis University School of Medicine, 3635 Vista Avenue, St Louis, MO 63110, USA
J Hepatol 38:434-40. 2003....
Iron toxicity and chelation therapyRobert S Britton
Int J Hematol 76:219-28. 2002..The use of the oral chelator deferiprone remains controversial, and work is continuing on the development of new orally effective iron chelators...
Treatment of patients with hepatitis C and normal serum aminotransferase levelsBruce R Bacon
Division of Gastroenterology and Hepatology, St Louis University Liver Center, St Louis University School of Medicine, St Louis, MO 63110, USA
Hepatology 36:S179-84. 2002....
Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosisRobert E Fleming
Department of Pediatrics, Saint Louis University School of Medicine, MO 63104, USA
Proc Natl Acad Sci U S A 99:10653-8. 2002..This study confirms the important role for TFR2 in iron homeostasis and provides a tool for investigating the excess iron absorption and abnormal iron distribution in iron-overload disorders...
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazoneBrent A Neuschwander-Tetri
University Liver Center, Department of Internal Medicine, Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, 3635 Vista Avenue, St Louis, MO 63110, USA
Hepatology 38:1008-17. 2003....
Contribution of the H63D mutation in HFE to murine hereditary hemochromatosisShunji Tomatsu
Edward A Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St Louis, MO 63104, USA
Proc Natl Acad Sci U S A 100:15788-93. 2003..These observations indicate that the H67D mutation leads to partial loss of Hfe function and can contribute to murine HH...
Infection with hepatitis C virus genotype 4 in the United StatesAndre C Lyra
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Saint Louis University School of Medicine, 3635 Vista Avenue, St. Louis, MO 63110, USA
J Clin Gastroenterol 38:68-71. 2004....
Treatment of nonalcoholic steatohepatitisBruce R Bacon
Curr Gastroenterol Rep 6:9. 2004
Human platelets express hemochromatosis protein (HFE) and transferrin receptor 2Jokke Hannuksela
Department of Clinical Chemistry, University of Oulu, Oulu, Finland
Eur J Haematol 70:201-6. 2003..HFE, the protein defective in hereditary hemochromatosis, and transferrin receptor 2 (TfR2) are two novel protein candidates that could be involved in mechanisms of iron transport across the platelet plasma membrane...
Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infectionHari H Diwakaran
Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, 3635 Vista Avenue, St. Louis, MO 63110-0250, USA
J Hepatol 36:687-91. 2002..These findings support the concept that the combination of HH-induced iron overload and HCV has a potentiating effect on hepatic fibrogenesis...
Chronic hepatitis C and normal ALT: considerations for treatmentBruce R Bacon
Am J Gastroenterol 99:1706-7. 2004..ALT levels are a poor marker of disease severity and/or indication for treatment in patients with chronic hepatitis C...
Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infectionStephen Pianko
Scripps Clinic and Research Foundation, La Jolla, CA 92037, USA
J Interferon Cytokine Res 22:483-9. 2002..IFN monotherapy nonresponder patients tended to have a higher HIC. With IFN plus ribavirin, the sustained virologic response rate was not affected by the HIC...
Pathogenesis of hereditary hemochromatosis: genetics and beyondRobert S Britton
Department of Internal Medicine, Saint Louis University School of Medicine, Mo 63110 0250, USA
Semin Gastrointest Dis 13:68-79. 2002..Future investigations will refine our knowledge of the mechanisms of action of HFE protein, the phenotypic variability observed in persons homozygous for the C282Y mutation, and the mechanisms responsible for non-HFE-related HH...
Managing hepatitis CBruce R Bacon
Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, Missouri, USA
Am J Manag Care 10:S30-40. 2004....
Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimensElizabeth M Brunt
Department of Pathology, Saint Louis University School of Medicine, St. Louis, Missouri 63110, USA
Hum Pathol 35:1070-82. 2004....
Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosisAbdul Waheed
Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA
Proc Natl Acad Sci U S A 99:3117-22. 2002....
Concurrence of histologic features of steatohepatitis with other forms of chronic liver diseaseElizabeth M Brunt
Saint Louis University Liver Center Department of Pathology, Saint Louis University Health Sciences Center, St Louis, Missouri, USA
Mod Pathol 16:49-56. 2003..Diabetes was reported in 35%, 25%, and 9%. The concurrence of clinical and histologic features of steatohepatitis with another chronic liver disease may be a reflection of the frequency of steatohepatitis in the population at large...
Macro-aspartate aminotransferase in a female with antibodies to hepatitis C virusJohn Collins
Departments of Pathology and Laboratory Medicine, Saint Louis University School of Medicine, St Louis, MO 63110, USA
Liver 22:501-6. 2002..A brief review of the clinical enzymology of AST and methods used to quantify serum macro-AST activity is provided...
Hepatology: small steps forwardBruce R Bacon
Gastroenterology 134:381. 2008
Workforce issues in hepatology: what is needed?Bruce R Bacon
Division of Gastroenterology and Hepatology, Saint Louis University Liver Center, Saint Louis University School of Medicine, St Louis, MO, USA
Hepatology 47:1801-4. 2008
Aldehydic products of lipid peroxidation do not directly activate rat hepatic stellate cellsJohn K Olynyk
Department of Medicine, University of Western Australia, Western Australian Institute of Medical Research, Perth, Australia
J Gastroenterol Hepatol 17:785-90. 2002..CONCLUSIONS: Aldehydic products of lipid peroxidation do not directly activate HSC in early culture and alternative pathways may be responsible for HSC activation during oxidative stress...
Evaluation of serum anion gap in patients with liver cirrhosis of diverse etiologiesHatim Hassan
Division of Nephrology, Saint Louis University School of Medicine, Saint Louis, MO, USA
Mt Sinai J Med 71:281-4. 2004..We found no difference in serum AG with different causes of cirrhosis. We also suggest a lower reference range for normal serum AG...
Hereditary hemochromatosis: update for 2003Stephen A Harrison
Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, 3635 Vista Avenue, St Louis, MO 63110-0250, USA
J Hepatol 38:S14-23. 2003
CD14-positive hepatic monocytes/macrophages increase in hereditary hemochromatosisKatherine L Leicester
School of Medicine and Pharmacology, University of Western Australia, Australia
Liver Int 24:446-51. 2004..In control human liver, Kupffer cells had a very low expression of CD14. These findings suggest that CD14-positive monocytes/macrophages may contribute to the process of hepatic fibrogenesis in HH...
Testing for hepatitis C virus infection should be routine for persons at increased risk for infectionMiriam J Alter
Division of Viral Hepatitis, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Ann Intern Med 141:715-7. 2004....
Hepatitis C: a 20-year debt comes dueJohn G McHutchison
Gastroenterology and Hepatology Research, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
Am J Manag Care 10:S20. 2004
Disease- and cell-specific expression of GP73 in human liver diseaseRehan Iftikhar
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, Missouri, USA
Am J Gastroenterol 99:1087-95. 2004..This expression pattern suggests the presence of two regulatory mechanisms, the first triggered during acute hepatocellular injury, the second during the progression of chronic liver disease...
A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patientsTing Tsung Chang
National Cheng Kung University Medical College, Tainan, Taiwan
Gastroenterology 129:1198-209. 2005..This randomized, dose-ranging, phase 2 study compared the efficacy and safety of entecavir with lamivudine in lamivudine-refractory patients...
Screening for hemochromatosisBruce R Bacon
Arch Intern Med 166:269-70. 2006
The ethanol metabolite, linolenic acid ethyl ester, stimulates mitogen-activated protein kinase and cyclin signaling in hepatic stellate cellsJianjun Li
Department of Internal Medicine, Division of Gastroenterology and Hepatology, The Brody School of Medicine, East Carolina University, 600 Moye Boulevard, Greenville, NC 27858 4354, USA
Life Sci 73:1083-96. 2003..The stimulation of intracellular signaling pathways in HSC by this well-characterized ethanol metabolite may contribute to ethanol-induced hepatic fibrogenesis...
Insurance, employment, and psychosocial consequences of a diagnosis of hereditary hemochromatosis in subjects without end organ damageNicholas J Shaheen
Center for Gastrointestinal Biology and Disease, and the Division of Digestive Diseases and Nutrition, University of North Carolina, Chapel Hill, North Carolina 27599, USA
Am J Gastroenterol 98:1175-80. 2003..However, the overall proportion of those with active insurance, the quality of life, and the psychological well-being of these subjects were similar to those of unaffected siblings...
Effect of protein kinase C activation and inhibition on rat hepatic stellate cell activationGrant A Ramm
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri 63110-0250, USA
Dig Dis Sci 48:790-6. 2003..The demonstration that hepatic stellate cell activation can be suppressed by PKC inhibitors suggests a role for PKC in the regulation of hepatic stellate cell activation...
Hepatology: where do we go from here?Bruce R Bacon
Gastroenterology 131:1373-4. 2006
Genetics in liver diseasesAntonello Pietrangelo
Center for Hemochromatosis, University Hospital of Modena, Via del Pozza 71, 41100 Modena, Italy
J Hepatol 46:1143-8. 2007..This article reports the highlights of the conference and summarizes the main conclusions and implications for clinical and experimental hepatology...
Orlistat in the treatment of NASH: a case seriesStephen A Harrison
Saint Louis University Liver Center, Division of Gastroenterology and Hepatology, St. Louis, Missouri 63110, USA
Am J Gastroenterol 98:926-30. 2003....
Hereditary hemochromatosis and alcohol: a fibrogenic cocktailRobert S Britton
Gastroenterology 122:563-5. 2002
Research Grants
- HEPATOTOXICITY OF EXPERIMENTAL HEMOCHROMATOSISBruce Bacon; Fiscal Year: 1993....
- HEPATIC FIBROGENESIS IN EXPERIMENTAL HEMOCHROMATOSISBruce Bacon; Fiscal Year: 2000....
- Signaling Pathways in Hepatic FibrogenesisBruce Bacon; Fiscal Year: 2005..Since activated HSC play a key role in hepatic fibrogenesis, these experiments will contribute to an improved understanding of the basic biochemical processes underlying hepatic fibrosis. ..
